Category: Law
Newly funded companies create medical innovations, help businesses improve productivity
PHILADELPHIA, PA (www.sep.benfranklin.org) – Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP) recently approved investments totaling $1,800,000 for nine early-stage Pennsylvania companies with promising technology innovations. Included in this is a $500,000 investment in Molecular Detection Inc. (MDI). MDI developed a quick method to detect drug resistant Staph infections. Investment details follow.
Ann Arbor SPARK has just released an update of available resources available
Are you interested in having a team of MBA students work on a problem for you during the fall? Each year, they accept proposals from sponsors looking to solve problems, identify new processes, or target opportunities for growth. Successful proposals:
- Address a real challenge or opportunity that has no existing obvious solution;
- Demand a set of actionable recommendations;
- Are important to the company and have strong support from senior-level management;
- Require a multidisciplinary approach; and
- May be completed in 14 weeks.
Participation comes from academic institutions and companies across the state
Waltham, Massachusetts - The Massachusetts Life Sciences Center’s 2010 Internship Challenge has received an overwhelming response since its February launch, with nearly 900 applicants seeking internships this summer. Over 130 companies from all sectors of the life sciences community have combed through hundreds of resumes, held numerous interviews, and selected interns to hire. Through the Challenge, 164 interns have been matched with 93 life sciences companies, a more than 50% increase from the 104 interns selected in 2009.
The Massachusetts Life Sciences Center’s Internship Challenge is a workforce development program focused on enhancing the talent pipeline for life sciences companies in Massachusetts while providing interns with practical, “hands on” experience that prepares them to step into the workforce ready to meet the job requirements of life sciences employers. The program is providing paid summer internships to undergraduates, graduate students, and recent college graduates from 46 different colleges and universities.
UC Berkeley, Deloitte and Prescience, Intl. are proud to offer 10 scholarships to the BioExec Institute 2010. Part of the success of this internationally-renowned program has been the diversity and depth of its participants, which has created a strong and powerful alumni network in this industry. We would therefore like to offer scholarships to the leadership of small companies with annual revenues under $10M and to academics, as well as employees of governmental and/or non-profit organizations. These scholarships finance nearly 50% of an attendee's program registration fee.
This is a rolling application process. Please click here to download the application form and submit to Chelsea Hewitt at chelsea@prescienceintl.com. You will be notified if your application is accepted within one week of your submission. Some of this year's faculty and speakers include:
- Mervyn J. Turner, Ph.D., Chief Strategy Officer, Merck & Co. Inc. & Sr. Vice President, Emerging Markets, Merck Research Laboratories
- Mark Edwards, President, Deloitte Recap, LLC
- Barbara Ryan, Managing Director, Deutsche Bank
- Dave Summa, Board of Directors, Sequoia Pharmaceuticals, Acumen Pharmaceuticals, and Agrivida, Inc.
- Christopher S. Boerner, Group Product Manager, Xolair Marketing, Genentech
- David Kessler, MD, JD, Best Selling Author and Former Commissioner of the US Food and Drug Administration (FDA)
- Martin Babler, President and CEO, Talima Therapeutics Inc.
- Casper DeClerq, Venture Partner, US Venture Partners
- Scott Evangelista, Principal, National Commercial Practice Leader, Deloitte Consulting LLP
- Dennis Schmatz, PhD, President, Medicines for Malaria Venture NA; Chair - Expert Scientific Advisory Board (ESAC) Medicines for Malaria Venture, Board Member,Medicines for Malaria Venture
- Keith Donnermeyer, Partner and National Life Sciences Sector Leader, Deloitte & Touche LLP
- Abhay Joshi, PhD, President & CEO, Alvine Pharmaceuticals
- Brian McRee, Director, Commercial Supply Planning, Genentech
- Kuo Bianchini Tong, Founder & President, Quorum Consulting
Center will provide $2.48 million to support four early-stage life sciences companies
Waltham, MA – The Massachusetts Life Sciences Center (the “Center”), a quasi-public agency tasked with implementing the state’s ten-year, $1 billion Life Sciences Initiative, today announced the awarding of $2.48 million in loans to four early-stage life sciences companies. The Center’s Accelerator Program provides loans of up to $750,000 to early-stage companies engaged in life sciences research and development, commercialization and manufacturing. The Center’s Board of Directors approved the first round of 2010 Accelerator loans today. Four companies were authorized to receive loans out of thirty-nine applications that were submitted to the Center and competitively peer-reviewed. A second round of the Program is scheduled for the Fall of 2010.
At two-year mark, state’s Life Sciences Initiative provides strong return on investment
Waltham, MA – The Massachusetts Life Sciences Center is providing a $50,000 grant to the Massachusetts Life Sciences Collaborative to support an initiative aimed at strengthening the state’s biomanufacturing sector through a Massachusetts Biomanufacturing Roundtable and the development of a comprehensive Biomanufacturing action agenda during the 2010 calendar year. The Biomanufacturing Roundtable includes participation from influential life sciences, biomanufacturing, academic, and government leaders, including Massachusetts Life Sciences Center President & CEO, Dr. Susan Windham-Bannister. The Roundtable is co-chaired by Taligen Therapeutics CEO Abbie Celniker, Acceleron Pharma Senior Vice President of Manufacturing Bob Steininger, and former Pfizer Vice President Mickey Koplove.
Application period opens on June 21st
Contact: Angus G. McQuilken, MLSC VP for Communications
Boston, MA – Governor Patrick, the Massachusetts Life Sciences Center, MassBio and MassMEDIC today urged qualifying companies to apply for the Therapeutic Discovery Tax Credit, a new federal program created under the Affordable Care Act to support biomedical research. Qualifying companies may apply to the new federal program starting on Monday, June 21, 2010 with applications due by July 21, 2010. Applicants will receive a determination no later than October 29, 2010. More information is available on the web site of the Massachusetts Life Sciences Center, www.masslifescience.com.
Albuquerque, NM (June 2,2010)- Cancer diagnostics company Biomoda, Inc. (OTC BB:BMOD) (www.biomoda.com) and Obio, a corporation formed to pursue public and private funding for cancer research in Ohio, signed a memorandum of understanding (MOU) to establish a CLIA-certified Biomoda clinical laboratory in Ohio to support ongoing research and development on Biomoda’s porphyrin-based assay for the detection of early-stage cancer.
The Clinical Laboratory Improvement Amendments (CLIA) were passed by congress in 1988 to establish standards for laboratory testing and ensure the accuracy and reliability of patient test results. Laboratories that meet CLIA standards are certified by the U.S. Department of Health and Human Services.
FOR IMMEDIATE RELEASE CONTACT Juan Martinez
Tuesday, May 25, 2010 Kim Haberlin
Heather Johnson
Caitlin Coyle
617-725-4025
Discuss area job growth under state's ten-year, $1 billion Life Sciences Initiative. 64% of dollars invested thus far have been in Central Massachusetts
WORCESTER – Tuesday, May 25, 2010 - Governor Deval Patrick and Susan Windham-Bannister, President & CEO of the Massachusetts Life Sciences Center, visited Worcester Polytechnic Institute's (WPI) Gateway Park today for a discussion of life sciences job growth in the park and the region. WPI recently received approval for a $6.6 million grant from the Center for Phase II construction at Gateway Park. The Governor met with leaders from WPI, the Massachusetts Academy of Math and Sciences, and Massachusetts Biomedical Initiatives (MBI), all of whom have benefitted from the Center's investment. The Governor also met employees of the companies and organizations located in the park, including employees of RXi Pharmaceuticals, a company that is participating in a cooperative research project with UMass Medical School (UMMS) that is funded through the Center's Cooperative Research Matching Grant Program. Both grants were made under the Patrick-Murray Administration's 10-year, $1 billion Life Sciences Initiative.
Media Release
May 20, 2010
Media inquiries
(Tucson, Arizona) The University of Arizona is releasing a report detailing the performance of the UA Tech Park and its significant contribution to Tucson and Pima County’s economy. The report, Economic Impacts of the University of Arizona Science and Technology Park - Calendar Year 2008, is available at www.uatechpark.org.
The UA Tech Park contributes $3.0 billion annually to Pima County’s economy. Total dollar impact is estimated based on output, wages and tax revenue. UA Tech Park tenants paid $593.3 million in direct wages to their employees.
The average wage for a UA Tech Park worker was $85,500 in 2008, more than twice the Pima County average of $39,900. Employment at the UA Tech Park has steadily increased since 1997. On average, the UA Tech Park has added 250 new jobs every year, over the past eleven year period. Most of the annual growth is the result of additional high wage jobs for skilled workers. UA Tech Park employment growth has outperformed the Tucson Metro Region, State of Arizona and the United States.
“The UA Tech Park is a critical component of the Southern Arizona high technology economy. The employment growth at the Park demonstrates the importance of a knowledge-based economy especially during periods of economic recession,” said Bruce Wright, Associate Vice President for University Research Parks.
